Oramed Pharmaceuticals (ORMP) P/E (2011 - 2026)
Oramed Pharmaceuticals (ORMP) P/E from Aug 31, 2011 to Jul 21, 2026. The TTM Oramed Pharmaceuticals (ORMP) P/E is 1.49. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Oramed Pharmaceuticals (ORMP)
| Year | P/E | Change |
|---|---|---|
| 2026 | 1.49 | -17.59% |
| 2025 | 1.81 | -135.70% |
| 2024 | -5.06 | -11.75% |
| 2023 | -5.73 | -49.87% |
| 2022 | -11.43 | -29.92% |
| 2021 | -16.31 | +194.70% |
| 2020 | -5.54 | -22.12% |
| 2019 | -7.11 | +117.81% |
| 2018 | -3.26 | -72.42% |
| 2017 | -11.83 | +64.15% |
| 2016 | -7.21 | -42.12% |
| 2015 | -12.45 | +71.50% |
| 2014 | -7.26 | -122.62% |
| 2013 | 32.10 | -582.91% |
| 2012 | -6.65 | -30.89% |
| 2011 | -9.62 | N/A |
Comparison Oramed Pharmaceuticals (ORMP) P/E with competitors
Oramed Pharmaceuticals (ORMP) P/E is 1.49.